Latest Insider Transactions at Prothena Corp Public LTD CO (PRTA)
This section provides a real-time view of insider transactions for Prothena Corp Public LTD CO (PRTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROTHENA CORP PUBLIC LTD CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROTHENA CORP PUBLIC LTD CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$120,000
$30.0 P/Share
|
|
Sep 15
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
|
Aug 24
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-75.76%
|
$300,000
$30.17 P/Share
|
|
Aug 24
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|
|
Aug 17
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
2,181
-14.57%
|
$69,792
$32.03 P/Share
|
|
Aug 17
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,181
+12.71%
|
$13,086
$6.41 P/Share
|
|
Aug 12
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
20,284
-61.32%
|
$649,088
$32.16 P/Share
|
|
Aug 12
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,284
+38.01%
|
$121,704
$6.41 P/Share
|
|
Aug 11
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
13,650
-51.62%
|
$436,800
$32.16 P/Share
|
|
Aug 11
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,650
+34.05%
|
$81,900
$6.41 P/Share
|
|
Aug 10
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
991
-7.19%
|
$31,712
$32.01 P/Share
|
|
Aug 10
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
991
+6.71%
|
$5,946
$6.41 P/Share
|
|
Aug 05
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
21,506
-37.92%
|
$688,192
$32.92 P/Share
|
|
Aug 05
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,506
+38.54%
|
$129,036
$6.41 P/Share
|
|
Aug 04
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
20,954
-62.09%
|
$670,528
$32.18 P/Share
|
|
Aug 04
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,954
+38.31%
|
$125,724
$6.41 P/Share
|
|
Aug 01
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$120,000
$30.52 P/Share
|
|
Aug 01
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
|
Jul 27
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
376
-2.86%
|
$12,032
$32.0 P/Share
|
|
Jul 27
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
376
+2.78%
|
$2,256
$6.41 P/Share
|
|
Jul 22
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
7,320
-69.58%
|
$234,240
$32.55 P/Share
|
|
Jul 22
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,320
+41.03%
|
$43,920
$6.73 P/Share
|
|
Jul 21
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
20,560
-43.33%
|
$678,480
$33.16 P/Share
|
|
Jul 21
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,560
+46.39%
|
$123,360
$6.73 P/Share
|
|
Jul 20
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$480,000
$32.9 P/Share
|
|
Jul 20
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.41 P/Share
|
|
Jul 20
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
42,120
-69.8%
|
$1,347,840
$32.53 P/Share
|
|
Jul 20
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,120
+48.17%
|
$252,720
$6.73 P/Share
|
|
Jul 06
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,000
-100.0%
|
$240,000
$30.0 P/Share
|
|
Jul 06
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+50.0%
|
$192,000
$24.9 P/Share
|
|
May 05
2022
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,062,736
-8.4%
|
$30,819,344
$29.02 P/Share
|
|
May 05
2022
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,062,736
+8.4%
|
$30,819,344
$29.02 P/Share
|
|
Apr 11
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
5,000
-78.1%
|
$175,000
$35.61 P/Share
|
|
Apr 11
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.41 P/Share
|
|
Apr 05
2022
|
Richard T Collier |
SELL
Open market or private sale
|
Direct |
5,000
-54.17%
|
$195,000
$39.42 P/Share
|
|
Apr 05
2022
|
Richard T Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+44.57%
|
$30,000
$6.41 P/Share
|
|
Jan 12
2022
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
300,000
+2.52%
|
$11,100,000
$37.5 P/Share
|
|
Jan 03
2022
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct |
5,000
-27.84%
|
$235,000
$47.96 P/Share
|
|
Jan 03
2022
|
Dennis J. Selkoe |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+38.93%
|
$45,000
$9.23 P/Share
|
|
Nov 23
2021
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,519
-79.87%
|
$257,583
$57.97 P/Share
|
|
Nov 23
2021
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,519
+50.0%
|
$67,785
$15.04 P/Share
|
|
Nov 19
2021
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$550,000
$55.0 P/Share
|
|
Nov 19
2021
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$100,000
$10.27 P/Share
|
|
Nov 01
2021
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
10,000
-52.98%
|
$560,000
$56.72 P/Share
|
|
Nov 01
2021
|
Carol D. Karp Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$150,000
$15.04 P/Share
|
|
Oct 27
2021
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-82.72%
|
$590,000
$59.47 P/Share
|
|
Oct 27
2021
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$100,000
$10.27 P/Share
|
|
Oct 20
2021
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
23,000
-75.62%
|
$1,380,000
$60.95 P/Share
|
|
Oct 20
2021
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,000
+30.77%
|
$506,000
$22.43 P/Share
|
|
Oct 01
2021
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
10,000
-59.0%
|
$680,000
$68.66 P/Share
|